Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1978 Aug 1;148(2):408–423. doi: 10.1084/jem.148.2.408

Nonproducer malignant tumor cells with rescuable sarcoma virus genome isolated from a recurrent Moloney sarcoma

PMCID: PMC2184942  PMID: 151722

Abstract

Cells from a secondary tumor developing at the site of a regressed Moloney sarcoma virus-induced tumor could be passaged in adult STU mice by intramuscular and intraperitoneal inoculation. The tumors induced by these cells, as well as by a cell line derived from it, grew progressively and led to death of the animals between 3 and 7 wk after tumor transplantation. No evidence for production of virus from these cells was obtained or for the presence of viral antigens (p30, gp69/71). From both cell variants, sarcoma virus genome could be rescued by infection with helper virus, resulting in the establishment of a cell line producing focus- and XC plaque-forming virus. The rescued producer cells very frequently also produced tumors which finally grew progressively. The nonproducer cells were not immunogenic, as was demonstrated in cross transplantation tests and in studies for cell-mediated cytotoxicity (CMC) and complement-dependent antibody- mediated cytotoxicity (AMC). The producer cells, however, were demonstrated to possess a strong immunogenicity. The nonproducer cells, though nonimmunogenic, revealed a weak immunosensitivity when used for challenge in the transplantation protection assay or as target cell for the demonstration of AMC and CMC, if the immune response was induced by cells producing the sarcoma-helper virus complex, but not by cells producing only helper virus. The nonproducer cells, as well as their rescued producer derivative, showed a stronger reactivity with cytotoxic antibodies than with cytotoxic cells, whereas the helper virus-producing cell line was comparably suitable as target cell for AMC and CMC. The recurrence of a regressed Moloney sarcoma is assumed to be the result of the occurrence of transformed nonproducer cells escaping immune destruction, and not as a consequence of a depleted immune resistance in the host.

Full Text

The Full Text of this article is available as a PDF (1.4 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aaronson S. A., Rowe S. P. Nonproducer clones of murine sarcoma virus transformed BALB-3T3 cells. Virology. 1970 Sep;42(1):9–19. doi: 10.1016/0042-6822(70)90233-3. [DOI] [PubMed] [Google Scholar]
  2. Altenburg B. C., Somers K., Steiner S. Altered microfilament structure in cells transformed with a temperature-sensitive transformation mutant of murine sarcoma virus. Cancer Res. 1976 Jan;36(1):251–257. [PubMed] [Google Scholar]
  3. Aoki T., Stephenson J. R., Aaronson S. A. Demonstration of a cell-surface antigen associated with murine sarcoma virus by immunoelectron microscopy. Proc Natl Acad Sci U S A. 1973 Mar;70(3):742–746. doi: 10.1073/pnas.70.3.742. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Ball J., McCarter J. A., Sunderland S. M. Evidence for helper independent murine sarcoma virus. I. Segregation of replication-defective and transformation-defective viruses. Virology. 1973 Nov;56(1):268–284. doi: 10.1016/0042-6822(73)90305-x. [DOI] [PubMed] [Google Scholar]
  5. Bean M. A., Pees H., FOGH J. E., Grabstald H., Oettgen H. F. Cytotoxicity of lymphocytes from patients with cancer of the urinary bladder: detection by a 3-H-proline microcytotoxicity test. Int J Cancer. 1974 Aug 15;14(2):186–197. doi: 10.1002/ijc.2910140207. [DOI] [PubMed] [Google Scholar]
  6. Cerottini J. C., Brunner K. T. Reversible inhibition of lymphocyte-mediated cytotoxicity by cytochalasin B. Nat New Biol. 1972 Jun 28;237(78):272–273. doi: 10.1038/newbio237272a0. [DOI] [PubMed] [Google Scholar]
  7. Collavo D., Colombatti A., Biasi G., Chieco-Bianchi L., Davies A. J. Immune reactivity in the Moloney strain of murine sarcoma virus oncogenesis: requirement of thymus-derived lymphocytes for in vivo protection. J Natl Cancer Inst. 1976 Mar;56(3):603–608. doi: 10.1093/jnci/56.3.603. [DOI] [PubMed] [Google Scholar]
  8. Davis S. Moloney sarcoma virus-induced tumors in athymic (nude) mice: growth pattern and antibody responses. J Natl Cancer Inst. 1975 Mar;54(3):793–794. doi: 10.1093/jnci/54.3.793. [DOI] [PubMed] [Google Scholar]
  9. Fefer A., McCoy J. L., Glynn J. P. Studies on the growth and regression of a transplantable Moloney sarcoma. Cancer Res. 1967 Nov;27(11):2207–2211. [PubMed] [Google Scholar]
  10. Fefer A., McCoy J. L., Perk K., Glynn J. P. Immunologic, virologic, and pathologic studies of regression of autochthonous Moloney sarcoma virus-induced tumors in mice. Cancer Res. 1968 Aug;28(8):1577–1585. [PubMed] [Google Scholar]
  11. Gazdar A. F. The response of NXW-NZB F1 hybrid mice to a murine sarcoma virus. Int Arch Allergy Appl Immunol. 1970;38(5):509–513. doi: 10.1159/000230303. [DOI] [PubMed] [Google Scholar]
  12. Gomard E., Duprez V., Henin Y., Levy J. P. H-2 region product as determinant in immune cytolysis of syngeneic tumour cells by anti-MSV T lymphocytes. Nature. 1976 Apr 22;260(5553):707–709. doi: 10.1038/260707a0. [DOI] [PubMed] [Google Scholar]
  13. Henney C. S., Bubbers J. E. Antigen-T lymphocyte interactions: inhibition by cytochalasin B. J Immunol. 1973 Jul;111(1):85–90. [PubMed] [Google Scholar]
  14. Hinshaw V. S., Schaffer F. L., Chatigny M. A. Evaluation of Moloney murine sarcoma and leukemia virus complex as a model for airborne oncogenic virus biohazards: survival of airborne virus and exposure of mice. J Natl Cancer Inst. 1976 Oct;57(4):775–778. doi: 10.1093/jnci/57.4.775. [DOI] [PubMed] [Google Scholar]
  15. Levy J. P., Leclerc J. C. The murine sarcoma virus-induced tumor: exception or general model in tumor immunology? Adv Cancer Res. 1977;24:1–66. doi: 10.1016/s0065-230x(08)61012-x. [DOI] [PubMed] [Google Scholar]
  16. Rowe W. P., Pugh W. E., Hartley J. W. Plaque assay techniques for murine leukemia viruses. Virology. 1970 Dec;42(4):1136–1139. doi: 10.1016/0042-6822(70)90362-4. [DOI] [PubMed] [Google Scholar]
  17. Russell S. W., Cochrane C. G. The cellular events associated with regression and progression of murine (Moloney) sarcomas. Int J Cancer. 1974 Jan 15;13(1):54–63. doi: 10.1002/ijc.2910130107. [DOI] [PubMed] [Google Scholar]
  18. Stephenson J. R., Aaronson S. A. Antigenic properties of murine sarcoma virus-transformed BALB-3T3 nonproducer cells. J Exp Med. 1972 Mar 1;135(3):503–515. doi: 10.1084/jem.135.3.503. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Strouk V., Grundner G., Fenyö E. M., Lamon E., Skurzak H., Klein G. Lack of distinctive surface antigen on cells transformed by murine sarcoma virus. J Exp Med. 1972 Aug 1;136(2):344–352. doi: 10.1084/jem.136.2.344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Stutman O. Delayed tumour appearance and absence of regression in nude mice infected with murine sarcoma virus. Nature. 1975 Jan 10;253(5487):142–144. doi: 10.1038/253142a0. [DOI] [PubMed] [Google Scholar]
  21. Tamerius J. D., Hellström I. In vitro demonstration of complement-dependent cytotoxic antibodies to Moloney sarcoma cells. J Immunol. 1974 Jun;112(6):1987–1996. [PubMed] [Google Scholar]
  22. Ting R. C., Bader A. V. A quantitative study on transformation of hamster embryo cells in vitro by murine sarcoma viruses (Harvey and Moloney). Virology. 1969 Oct;39(2):194–203. doi: 10.1016/0042-6822(69)90039-7. [DOI] [PubMed] [Google Scholar]
  23. Wang E., Goldberg A. R. Changes in microfilament organization and surface topogrophy upon transformation of chick embryo fibroblasts with Rous sarcoma virus. Proc Natl Acad Sci U S A. 1976 Nov;73(11):4065–4069. doi: 10.1073/pnas.73.11.4065. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Weiland E., Mussgay M. Detection of cytotoxic lymphoid spleen cells from STU-mice with Moloney sarcoma by a 3H-proline microcytotoxicity assay. Med Microbiol Immunol. 1976 Jun 1;162(2):81–87. doi: 10.1007/BF02121319. [DOI] [PubMed] [Google Scholar]
  25. Weiland E., Mussgay M. Presence of splenic suppressor cells in mice bearing regressively growing Moloney sarcomas and their absence in progressor mice. Eur J Cancer. 1977 Jul;13(7):705–711. doi: 10.1016/0014-2964(77)90057-3. [DOI] [PubMed] [Google Scholar]
  26. Weiland E., Mussgay M. Tumor inhibiting capacity of spleen and lymph node cells from mice with murine sarcoma virus (MSV-M)-induced tumors. Z Immunitatsforsch Exp Klin Immunol. 1975 Nov;150(5):414–423. [PubMed] [Google Scholar]
  27. Weiland E., Weiland F. Transplantierbarer Aszitestumor aus einer Maus mit einem Moloneysarkom: Tumor-, Antigen- und Viruseigenschaften. Z Immunitatsforsch Exp Klin Immunol. 1974 Nov;148(2):151–161. [PubMed] [Google Scholar]
  28. Weiland F., Ueberschär S., Straub O. C., Kaaden O. R., Dietzschold B. C-type particles in cultured lymphocytes from highly leukemic cattle. Intervirology. 1974;4(3):140–149. doi: 10.1159/000149853. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES